215 related articles for article (PubMed ID: 3142716)
21. Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic ossification after excision.
Sodemann B; Persson PE; Nilsson OS
Arch Orthop Trauma Surg; 1990; 109(2):53-6. PubMed ID: 2107800
[TBL] [Abstract][Full Text] [Related]
22. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
Barthel T; Baumann B; Nöth U; Eulert J
Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
[TBL] [Abstract][Full Text] [Related]
23. The use of cobalt therapy to prevent heterotopic ossification after total hip arthroplasty.
Sudanese A; Tabarroni M; Busanelli L; Testoni M; Toni A; Spagnolli MF; Fanton F; Brizio L; Giunti A
Chir Organi Mov; 1996; 81(2):89-106. PubMed ID: 8968113
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis with indomethacin for heterotopic ossification after Chiari osteotomy of the pelvis.
Randelli G; Romanò CL
J Bone Joint Surg Am; 1992 Oct; 74(9):1344-6. PubMed ID: 1429789
[TBL] [Abstract][Full Text] [Related]
25. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects.
Cella JP; Salvati EA; Sculco TP
J Arthroplasty; 1988; 3(3):229-34. PubMed ID: 3141590
[TBL] [Abstract][Full Text] [Related]
26. [Anterior intertrochanteric ossification after total hip arthroplasty].
Dorn U; Grethen C; Neumann D
Z Orthop Ihre Grenzgeb; 2003; 141(2):195-200. PubMed ID: 12695957
[TBL] [Abstract][Full Text] [Related]
27. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
28. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty.
McMahon JS; Waddell JP; Morton J
J Arthroplasty; 1991 Sep; 6(3):259-64. PubMed ID: 1940932
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study.
Schneider J; Maffulli N; Eschweiler J; Bell A; Hildebrand F; Migliorini F
Sci Rep; 2023 Nov; 13(1):20210. PubMed ID: 37980449
[TBL] [Abstract][Full Text] [Related]
30. Heterotopic ossification following total hip arthroplasty: a review.
Hu HP; Slooff TJ; van Horn JR
Acta Orthop Belg; 1991; 57(2):169-82. PubMed ID: 1908171
[TBL] [Abstract][Full Text] [Related]
31. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M
Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
33. Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis.
Sundaram NA; Murphy JC
Clin Orthop Relat Res; 1986 Jun; (207):223-6. PubMed ID: 3087671
[TBL] [Abstract][Full Text] [Related]
34. [Indomethacin--short-term therapy vs. single low dosage radiation for prevention of periarticular ossifications after total hip endoprosthesis].
Bremen-Kühne R; Stock D; Franke C
Z Orthop Ihre Grenzgeb; 1997; 135(5):422-9. PubMed ID: 9446435
[TBL] [Abstract][Full Text] [Related]
35. Radiation therapy to prevent heterotopic ossification after cementless total hip arthroplasty.
Kennedy WF; Gruen TA; Chessin H; Gasparini G; Thompson W
Clin Orthop Relat Res; 1991 Jan; (262):185-91. PubMed ID: 1898645
[TBL] [Abstract][Full Text] [Related]
36. Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty.
Kjaersgaard-Andersen P; Pedersen P; Kristensen SS; Schmidt SA; Pedersen NW
Clin Orthop Relat Res; 1988 Sep; (234):102-9. PubMed ID: 3136963
[TBL] [Abstract][Full Text] [Related]
37. Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication.
Kienapfel H; Koller M; Wüst A; Sprey C; Merte H; Engenhart-Cabillic R; Griss P
Arch Orthop Trauma Surg; 1999; 119(5-6):296-302. PubMed ID: 10447627
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
39. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB
J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
